Literature DB >> 34001996

Changes in retinal layers in type 1 diabetes mellitus without retinopathy measured by spectral domain and swept source OCTs.

Elvira Orduna-Hospital1,2, Ana Sanchez-Cano3,4, Lorena Perdices3, Javier Acha3,5, Elena María Lopez-Alaminos5, Isabel Pinilla3,6.   

Abstract

To evaluate changes in inner retinal layer (IRL) thicknesses in patients with type 1 diabetes mellitus (DM1) with no diabetic retinopathy (DR) using two different optical coherence tomography (OCT) devices. Ninety DM1 and 60 healthy eyes were evaluated using spectral domain (SD)-OCT and swept source (SS)-OCT to measure changes in the retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL) and inner nuclear layer (INL) thicknesses in all Early Treatment of Diabetic Retinopathy Study (ETDRS) macular areas. Functional tests were performed in both groups, including ETDRS with 100, 2.5 and 1.25% contrast, and color vision. The mean ages were 42.93 ± 13.62 and 41.52 ± 13.05 years in the diabetic and control groups, respectively. Visual acuity (VA) with ETDRS 1.25% was lower in the DM1 patients. Both ETDRS 2.5% and color vision were lower in the DM1 group but did not reach statistical significance. Retinal thicknesses in the central area and in the vertical outer areas were higher in the DM1 group. Differences were found in the IRL with no changes in the outer ones. Long-term DM1 patients with no DR maintained visual function, with a decrease in VA with 1.25% ETDRS contrast. Macular thickness measurements were higher using Spectralis SD-OCT than DRI Triton SS-OCT, and DM1 patients had a decrease in IRL thickness, especially in the GCL at the parafoveal level, generating thinning of the RNFL in the peripheral areas. There were no differences in outer retinal layer (ORL) thickness.

Entities:  

Year:  2021        PMID: 34001996     DOI: 10.1038/s41598-021-89992-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  32 in total

1.  Short-wavelength automated perimetry in type I diabetic patients without retinal involvement: a test modification to decrease test duration.

Authors:  Majid Abrishami; Ramin Daneshvar; Zakiyeh Yaghubi
Journal:  Eur J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 2.597

2.  Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings.

Authors:  Sengül C Ozdek; M Alper Erdinç; Gökhan Gürelik; Bahri Aydin; Umut Bahçeci; Berati Hasanreisoğlu
Journal:  Ophthalmologica       Date:  2005 Mar-Apr       Impact factor: 3.250

3.  Early neural and vascular changes in the adolescent type 1 and type 2 diabetic retina.

Authors:  Kevin W Bronson-Castain; Marcus A Bearse; Jessica Neuville; Soffia Jonasdottir; Barbara King-Hooper; Shirin Barez; Marilyn E Schneck; Anthony J Adams
Journal:  Retina       Date:  2012-01       Impact factor: 4.256

4.  Early detection of retinal thickness changes in diabetes using Optical Coherence Tomography.

Authors:  Delia Cabrera DeBuc; Gábor Márk Somfai
Journal:  Med Sci Monit       Date:  2010-03

5.  [Characters of contrast sensitivity in diabetic patients without diabetic retinopathy].

Authors:  Tang-sheng Sun; Mao-nian Zhang
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2012-01

6.  Association between retinal neuronal degeneration and visual function impairment in type 2 diabetic patients without diabetic retinopathy.

Authors:  TiePei Zhu; Jin Ma; YongHao Li; Zheng Zhang
Journal:  Sci China Life Sci       Date:  2015-05-08       Impact factor: 6.038

Review 7.  Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision.

Authors:  F M Ewing; I J Deary; M W Strachan; B M Frier
Journal:  Endocr Rev       Date:  1998-08       Impact factor: 19.871

8.  Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.

Authors:  Elliott H Sohn; Hille W van Dijk; Chunhua Jiao; Pauline H B Kok; Woojin Jeong; Nazli Demirkaya; Allison Garmager; Ferdinand Wit; Murat Kucukevcilioglu; Mirjam E J van Velthoven; J Hans DeVries; Robert F Mullins; Markus H Kuehn; Reinier Otto Schlingemann; Milan Sonka; Frank D Verbraak; Michael David Abràmoff
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

9.  Farnsworth-Munsell 100-hue test for patients with diabetes mellitus.

Authors:  D Utku; L S Atmaca
Journal:  Ann Ophthalmol       Date:  1992-06

10.  Changes in frequency-doubling perimetry in patients with type I diabetes prior to retinopathy.

Authors:  Isabel Pinilla; Antonio Ferreras; Miriam Idoipe; Ana I Sanchez-Cano; Diana Perez-Garcia; Laura X Herrera; Maria J Pinilla; Emilio Abecia
Journal:  Biomed Res Int       Date:  2013-11-11       Impact factor: 3.411

View more
  3 in total

1.  Retinal Vascularization Abnormalities Studied by Optical Coherence Tomography Angiography (OCTA) in Type 2 Diabetic Patients with Moderate Diabetic Retinopathy.

Authors:  Guisela Fernández-Espinosa; Ana Boned-Murillo; Elvira Orduna-Hospital; María Dolores Díaz-Barreda; Ana Sánchez-Cano; Sofía Bielsa-Alonso; Javier Acha; Isabel Pinilla
Journal:  Diagnostics (Basel)       Date:  2022-02-01

2.  Current and Future Treatments for Diabetic Retinopathy.

Authors:  Francine Behar-Cohen; Anat Loewenstein
Journal:  Pharmaceutics       Date:  2022-04-07       Impact factor: 6.321

3.  Associations Between Peripapillary Retinal Nerve Fiber Layer and Choroidal Thickness With the Development and Progression of Diabetic Retinopathy.

Authors:  Xia Gong; Wei Wang; Kun Xiong; Lanhua Wang; Wangting Li; Yuting Li; Meng Yuan; Xiao Guo; Shaochong Zhang; Xiaoling Liang; Hua Liu; Wenyong Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-02-01       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.